Evidence map›Paper›PMID 25348465›Full record

ArticleRadiation oncology (London, England)2014

Assessment of a model based optimization engine for volumetric modulated arc therapy for patients with advanced hepatocellular cancer.

Antonella Fogliata, Po-Ming Wang, Francesca Belosi, Alessandro Clivio, Giorgia Nicolini, Eugenio Vanetti, Luca Cozzi

Abstract read
In one paragraph

Article in Radiation oncology (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Advances in Automated Treatment Planning.Seminars in radiation oncology · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Antonella FogliataOncology Institute of Southern Switzerland, Via ospedale, 6504, Bellinzona, Switzerland. afc@iosi.ch.
Po-Ming WangDepartment of Radiation Oncology, Cheng-Ching General Hospital, Taichung, Taiwan. lucozzi@iosi.ch.
Francesca BelosiOncology Institute of Southern Switzerland, Via ospedale, 6504, Bellinzona, Switzerland. lucozzi@iosi.ch.
Alessandro ClivioOncology Institute of Southern Switzerland, Via ospedale, 6504, Bellinzona, Switzerland. lucozzi@iosi.ch.
Giorgia NicoliniOncology Institute of Southern Switzerland, Via ospedale, 6504, Bellinzona, Switzerland. lucozzi@iosi.ch.
Eugenio VanettiOncology Institute of Southern Switzerland, Via ospedale, 6504, Bellinzona, Switzerland. lucozzi@iosi.ch.
Luca CozziOncology Institute of Southern Switzerland, Via ospedale, 6504, Bellinzona, Switzerland. lucozzi@iosi.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo evaluate in-silico the performance of a model-based optimization process for volumetric modulated arc therapy (RapidArc) applied to hepatocellular cancer treatments. PATIENTS AND

methods45 clinically accepted RA plans were selected to train a knowledge-based engine for the prediction of individualized dose-volume constraints. The model was validated on the same plans used for training (closed-loop) and on a set of other 25 plans not used for the training (open-loop). Dose prescription, target size, localization in the liver and arc configuration were highly variable in both sets to appraise the power of generalization of the engine. Quantitative dose volume histogram analysis was performed as well as a pass-fail analysis against a set of 8 clinical dose-volume objectives to appraise the quality of the new plans.

resultsQualitative and quantitative equivalence was observed between the clinical and the test plans. The use of model-based optimization lead to a net improvement in the pass-rate of the clinical objectives compared to the plans originally optimized with standard methods (this pass-rate is the frequency of cases where the objectives are respected vs. the cases where constraints are not fulfilled). The increase in the pass-rate resulted of 2.0%, 0.9% and 0.5% in a closed-loop and two different open-loop validation experiments.

conclusionsA knowledge-based engine for the optimization of RapidArc plans was tested and lead to clinically acceptable plans in the case of hepatocellular cancer radiotherapy. More studies are needed before a broad clinical use.

Indexed as

Computational BiologyModels, StatisticalFollow-Up StudiesHumansLiver NeoplasmsPrognosisRadiotherapy DosageRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedRetrospective Studies

Identifiers

PMID25348465
PMCPMC4219039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.